ClinicalTrials.Veeva

Menu

Omics Sequencing of Exosomes in Body Fluids of Patients With Acute Lung Injury

N

Nanfang Hospital, Southern Medical University

Status

Enrolling

Conditions

Acute Lung Injury

Treatments

Diagnostic Test: The lungs causes and extrapulmonary factors

Study type

Observational

Funder types

Other

Identifiers

NCT05058768
NFEC-2021-143

Details and patient eligibility

About

The exosomes in the experimental group and the control group were sequenced to find the difference of the two groups, providing a basis for subsequent basic research.

Full description

This study is an observational study, mainly collected by infection, trauma, burns and other non cardiac causes without any related comprehensive character drug treatment of acute respiratory distress (ARDS) in patients with blood, urine or alveolar lavage fluid specimens, used to extract exosomes for omics sequencing, relevant histomorphic variations in exosomes of this disease were obtained, In addition, functional verification of genes or proteins with different changes will be carried out to provide clinical basis for subsequent basic research.

Enrollment

180 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Inclusion criteria of experimental group:

  • Signed informed consent voluntarily;
  • Age: >18 years old, gender: no restrictions ;
  • Patients with known clinical manifestations of respiratory impairment or new/aggravated respiratory symptoms diagnosed within one week of onset according to the Berlin definition guidelines.

Control group inclusion criteria:

  • Age ≥18 years old (including 18 years old), male and female;
  • Male weight ≥50 kg, female weight ≥45kg, and body mass index (BMI) between 19 and 26(inclusive), BMI= weight (kg)/ height (㎡);
  • No smoking, alcohol addiction, no history of drug abuse;
  • No diabetes, asthma, copd, chronic renal insufficiency and other basic diseases; No history of major diseases or infectious diseases (including hepatitis B, hepatitis C, HIV, syphilis);
  • Those who have not taken drugs recently.

Exclusion criteria

Exclusion criteria of experimental group:

  • Patients with diabetes, chronic renal insufficiency, malignant tumors and other basic diseases;
  • severe malnutrition;
  • Pregnant or lactating women;
  • The researcher judged that he was not suitable to participate in this study.

Exclusion criteria for the control group:

  • pregnant or lactation women;
  • severe malnutrition;
  • The researcher judged that he was not suitable to participate in this study.

Trial design

180 participants in 2 patient groups

control group
Description:
Healthy people served as the control group
experimental group
Description:
Patients with acute lung injury were treated as the experimental group.
Treatment:
Diagnostic Test: The lungs causes and extrapulmonary factors

Trial contacts and locations

1

Loading...

Central trial contact

zhuping M zheng, bachelor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems